TLDR OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.
A woman in her 30s with a history of trichotillomania (TTM) and chronic migraines showed significant improvement in TTM symptoms and hair regrowth after receiving off-label onabotulinumtoxinA (OBTA) treatment, initially intended for her migraines. Despite previous unsuccessful treatments with behavioral therapy and SSRIs, OBTA injections (45 units total) in the scalp led to marked improvement in TTM symptoms and hair regrowth as early as 12 weeks post-treatment, with sustained effects and further hair regrowth observed after one year and four treatment cycles.
8 citations
,
September 2021 in “Skin appendage disorders” Trichotillomania treatment is most successful with a mix of behavioral therapy, medication, and social support.
24 citations
,
June 2020 in “Dermatologic Therapy” New drugs like N-acetylcysteine and dronabinol show promise for treating hair-pulling disorder.
Botulinum toxin shows promise for treating scalp sweating but not for hair growth.
Onabotulinumtoxin-A effectively treated a painful scalp condition when other treatments failed.
March 2014 in “Journal of The American Academy of Dermatology” The document lists various dermatology topics, treatments, and diagnostic methods.
July 2025 in “Actas Dermo-Sifiliográficas” Trichodynia is a challenging scalp condition to treat, needing gentle care and more research for better solutions.
1 citations
,
January 2019 in “Paediatrics and Child Health” The document concludes that understanding hair biology and recognizing hair conditions are crucial for managing and treating hair loss in children.
